Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer

Eur Urol. 2022 Jul;82(1):146-147. doi: 10.1016/j.eururo.2022.03.018. Epub 2022 Mar 25.
No abstract available

MeSH terms

  • Androgen Receptor Antagonists
  • Hormones
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / pathology
  • Pyrazoles

Substances

  • Androgen Receptor Antagonists
  • Hormones
  • Pyrazoles
  • darolutamide